Premier Alternatives

GenoPalate

Milwaukee, WI · Founded 2016 · Privately Held (backing)

Developer of a genetic data analytics platform designed to empower customers to eat healthy by assessing their genes. GenoPalate is based in Milwaukee, WI and was founded in 2016. Its last reported valuation was $21 million in Oct 2022. It has raised $13.3 million across 7 recorded rounds; the latest was a $250,000 seed round in Feb 2026.

Last reported valuation
$21.0M
Oct 2026
Priced at
—
Total raised
$13.3M
Last round
Seed Round
Feb 2026

GenoPalate key facts

as of Oct 2026
  • Developer of a genetic data analytics platform designed to empower customers to eat healthy by assessing their genes.
  • GenoPalate is valued at approximately $21.0M as of Oct 2026 (last reported valuation).
  • It has raised $13.3M across 7 recorded rounds; the latest was Seed Round ($250K) in Feb 2026.
  • Notable investors include gener8tor, gBETA, Wisconsin Economic Development, BrightStar Wisconsin Foundation, Startup Milwaukee — 6 tracked in total.
  • GenoPalate has filed 7 Form Ds with the SEC since 2018, most recently Dec 2024 ($3.0M sold to 4 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$21.0M

GenoPalate's last reported valuation, Oct 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of GenoPalate with a free account
  • ·Watch GenoPalate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

GenoPalate funding rounds

7 rounds
Feb 2026Seed Round$250KSEC filing▮
Oct 2024Seed Round$3.0MSEC filing▮
Oct 2022Early Stage VC$6.0MSEC filing▮
Dec 2020Seed Round$4.0MSEC filing▮
Dec 2019Seed Round$1.0MSEC filing▮
Full funding history →

GenoPalate valuation

GenoPalate's last reported valuation was $21 million in Oct 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has GenoPalate raised?

GenoPalate has raised $13.3 million across 7 recorded rounds since 2018. The largest was a $709,095 seed round in Nov 2018; the most recent was a $250,000 seed round in Feb 2026.

GenoPalate has filed 7 Form Ds with the SEC since 2018, most recently in Dec 2024 ($3 million sold to 4 investors).

GenoPalate investors

6 investors are on record for GenoPalate, including gener8tor, gBETA, Wisconsin Economic Development and BrightStar Wisconsin Foundation. The seed round in Feb 2026 drew 1 investor.

About GenoPalate

Developer of a genetic data analytics platform designed to empower customers to eat healthy by assessing their genes. The company's platform offers a proprietary analysis of genome-wide nutrigenetic profiles from partnered or third-party labs-collected genomic DNA data to develop a line of digital and physical personalized nutrition products, enabling customers to get a comprehensive report about their distinctive nutrition needs.

Sector
Healthcare
HQ
Milwaukee, WI, United States
Founded
2016
Employees
13
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.